Creation of a head and neck Keloid quality of life questionnaire. (30th September 2015)

• Record Type: Journal Article
• Authors: Guy, W. Marshall; Pattisapu, Prasanth; Ongkasuwan, Julina; Brissett, Anthony E.
• Is Part Of: Laryngoscope. Volume 125:Number 12(2015:Dec.)
• Page Start: 2672
• Page End: 2676
• Publication Date: 2015-09-30
• Subjects: Keloid -- quality of life -- hypertrophic scar -- scar; Otolaryngology -- Periodicals; 617.51005
• DOI: 10.1002/lary.25309
• Languages: English
• ISSNs: 0023-852X

Abstract

Abstract : Objectives: Create a head‐and‐neck keloid quality of life (QOL) questionnaire. Demonstrate the reliability of the keloid‐specific QOL scale according to test‐retest and internal consistency standards. Study Design: Prospective cohort study. Methods: Patients presenting to a keloid clinic in a tertiary referral institution between April 2012 and February 2013 were enrolled on their first visit. They were administered a questionnaire assessing demographics and a 21‐item Likert keloid‐specific survey assessing symptomatology, self‐esteem, social functioning, and therapeutic motivation during their first three visits. Reliability of the keloid questionnaire was assessed for internal consistency (Cronbach's alpha) and test‐retest correlations. Patients were treated with Kenalog steroid injections at each visit. The 126‐point total score from the questionnaire was then compared to each subscale (physical symptoms, self‐esteem, social function, and medical motivation) using a Pearson coefficient. Results: The keloid QOL questionnaire showed a Cronbach's alpha of 0.87 for the overall questionnaire and ranged from 0.66 to 0.86 for individual questions. The test‐retest Pearson's R was 0.70 between visits 1 and 2 and 0.77 between visits 2 and 3. The Pearson correlation between symptoms, self‐esteem, social functioning, and medical motivation subscales and the overall scale were 0.77, 0.73, 0.72, and 0.57, respectively. Conclusion: This head and neck keloid‐specific QOL questionnaire proved to be a reproducible method of reliably assessing QOL burden on patients with head and neck keloids. Level of Evidence: N/A. Laryngoscope, 125:2672–2676, 2015